# Rein Therapeutics, Inc.: filings

RNTX · Nasdaq · CIK 1420565 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rntx.md) · [Financials](/companies/rntx/financials.md) · [Filings](/companies/rntx/filings.md) · [Insiders](/companies/rntx/insiders.md)

## Reports and events: 164 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 141, 8-K 88, 3 41, 10-Q 28, 424B5 16, CORRESP 15, SC 13D/A 13, UPLOAD 13, EFFECT 12, DEFA14A 11, SC 13G/A 10, 10-K 9, DEF 14A 9, 4/A 8, S-8 8, SC 13G 7, SCHEDULE 13G/A 7, S-3 6, 10-K/A 5, D 5, PRE 14A 5, S-1 5, SCHEDULE 13G 5, ARS 4, DRS/A 4, SC 13D 4, CT ORDER 2, DRS 2, DRSLTR 2, NT 10-K 2, S-1/A 2, 144 1, 3/A 1, 424B3 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERTNAS 1, DEL AM 1, FWP 1, POS AM 1, S-3/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-04 | 16:31 ET | [8-K](/filings/0001193125-26-383726.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-383726 |
| 2026-08-27 | 16:05 ET | [8-K](/filings/0001193125-26-371260.md) | 3.01 Delisting notice | 0001193125-26-371260 |
| 2026-08-14 | 06:34 ET | [10-Q](/filings/0001193125-26-350270.md) | Quarterly report, period 2026-06-30 | 0001193125-26-350270 |
| 2026-07-21 | 16:10 ET | [8-K](/filings/0001193125-26-310315.md) | 5.07 Shareholder vote results | 0001193125-26-310315 |
| 2026-06-08 | 09:17 ET | [DEF 14A](/filings/0001193125-26-260809.md) | Proxy statement, period 2026-07-20 | 0001193125-26-260809 |
| 2026-05-15 | 07:56 ET | [10-Q](/filings/0001193125-26-225352.md) | Quarterly report, period 2026-03-31 | 0001193125-26-225352 |
| 2026-05-04 | 16:12 ET | [8-K](/filings/0001193125-26-204006.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-204006 |
| 2026-04-28 | 17:29 ET | [S-1](/filings/0001193125-26-187803.md) | Registration statement | 0001193125-26-187803 |
| 2026-04-27 | 06:51 ET | [10-K/A](/filings/0001193125-26-178787.md) | Annual report, amended, period 2025-12-31 | 0001193125-26-178787 |
| 2026-03-26 | 16:36 ET | [10-K](/filings/0001193125-26-126385.md) | Annual report, period 2025-12-31 | 0001193125-26-126385 |
| 2026-03-02 | 06:02 ET | [8-K](/filings/0001193125-26-084012.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-084012 |
| 2026-02-19 | 16:37 ET | [8-K](/filings/0001193125-26-059545.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-059545 |
| 2026-01-16 | 17:25 ET | [8-K](/filings/0001193125-26-015524.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-015524 |
| 2025-12-11 | 17:20 ET | [8-K](/filings/0001193125-25-316225.md) | 1.02 Termination of a material agreement | 0001193125-25-316225 |
| 2025-11-14 | 08:00 ET | [10-Q](/filings/0001193125-25-281622.md) | Quarterly report, period 2025-09-30 | 0001193125-25-281622 |
| 2025-11-03 | 07:45 ET | [8-K](/filings/0001193125-25-261706.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-261706 |
| 2025-10-24 | 17:08 ET | [8-K](/filings/0001193125-25-250175.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-250175 |
| 2025-10-09 | 07:45 ET | [8-K](/filings/0001193125-25-235152.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-235152 |
| 2025-09-22 | 08:00 ET | [8-K](/filings/0001193125-25-210050.md) | 8.01 Other events | 0001193125-25-210050 |
| 2025-09-09 | 08:00 ET | [8-K](/filings/0001193125-25-198816.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-198816 |
| 2025-09-03 | 17:03 ET | [S-1](/filings/0001193125-25-195041.md) | Registration statement | 0001193125-25-195041 |
| 2025-08-19 | 08:06 ET | [8-K](/filings/0001193125-25-183073.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-183073 |
| 2025-08-14 | 16:03 ET | [10-Q](/filings/0000950170-25-108836.md) | Quarterly report, period 2025-06-30 | 0000950170-25-108836 |
| 2025-07-30 | 09:04 ET | [8-K](/filings/0001193125-25-168830.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-168830 |
| 2025-07-23 | 16:01 ET | [8-K](/filings/0001193125-25-163400.md) | 5.07 Shareholder vote results | 0001193125-25-163400 |
| 2025-07-11 | 16:01 ET | [8-K](/filings/0001193125-25-158192.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-158192 |
| 2025-06-24 | 16:01 ET | [8-K](/filings/0001193125-25-145711.md) | 8.01 Other events | 0001193125-25-145711 |
| 2025-06-12 | 16:24 ET | [8-K](/filings/0001193125-25-139950.md) | 8.01 Other events | 0001193125-25-139950 |
| 2025-05-15 | 16:18 ET | [8-K](/filings/0001193125-25-120824.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-120824 |
| 2025-05-15 | 16:06 ET | [10-Q](/filings/0000950170-25-072607.md) | Quarterly report, period 2025-03-31 | 0000950170-25-072607 |
| 2025-05-12 | 16:30 ET | [DEF 14A](/filings/0001193125-25-117820.md) | Proxy statement, period 2025-06-24 | 0001193125-25-117820 |
| 2025-04-30 | 17:27 ET | [10-K/A](/filings/0001193125-25-107666.md) | Annual report, amended, period 2024-12-31 | 0001193125-25-107666 |
| 2025-04-22 | 08:58 ET | [8-K](/filings/0001193125-25-087955.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-087955 |
| 2025-04-17 | 16:14 ET | [8-K](/filings/0001193125-25-084340.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-25-084340 |
| 2025-04-07 | 16:02 ET | [10-K](/filings/0000950170-25-051566.md) | Annual report, period 2024-12-31 | 0000950170-25-051566 |
| 2025-01-10 | 16:06 ET | [8-K](/filings/0001193125-25-004443.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-004443 |
| 2024-11-14 | 16:08 ET | [8-K](/filings/0001193125-24-258568.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-258568 |
| 2024-11-14 | 16:03 ET | [10-Q](/filings/0000950170-24-127019.md) | Quarterly report, period 2024-09-30 | 0000950170-24-127019 |
| 2024-08-21 | 16:17 ET | [8-K](/filings/0001193125-24-204425.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-204425 |
| 2024-08-14 | 17:23 ET | [8-K](/filings/0001193125-24-200739.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-200739 |
| 2024-08-14 | 17:12 ET | [10-Q](/filings/0000950170-24-097199.md) | Quarterly report, period 2024-06-30 | 0000950170-24-097199 |
| 2024-07-26 | 16:36 ET | [8-K](/filings/0001193125-24-186279.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-186279 |
| 2024-07-09 | 08:30 ET | [DEF 14A](/filings/0001193125-24-176585.md) | Proxy statement, period 2024-08-20 | 0001193125-24-176585 |
| 2024-06-05 | 06:58 ET | [8-K](/filings/0001193125-24-154675.md) | 5.08 Item not in the standard list; 8.01 Other events | 0001193125-24-154675 |
| 2024-05-16 | 17:01 ET | [8-K](/filings/0001193125-24-140688.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-140688 |
| 2024-05-15 | 17:16 ET | [8-K](/filings/0001193125-24-139510.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-139510 |
| 2024-05-15 | 17:08 ET | [10-Q](/filings/0000950170-24-060583.md) | Quarterly report, period 2024-03-31 | 0000950170-24-060583 |
| 2024-05-01 | 17:25 ET | [8-K](/filings/0001193125-24-127657.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-127657 |
| 2024-05-01 | 08:40 ET | [8-K](/filings/0001193125-24-126425.md) | 2.02 Results of operations; 8.01 Other events | 0001193125-24-126425 |
| 2024-04-29 | 08:33 ET | [10-K/A](/filings/0001193125-24-120235.md) | Annual report, amended, period 2023-12-31 | 0001193125-24-120235 |

Page 1 of 4. [Older](/companies/rntx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.